WATSON 607 (Labetalol 300 mg)

Pill imprint WATSON 607 has been identified as Labetalol hydrochloride 300 mg.

Labetalol is used in the treatment of high blood pressure; hypertensive emergency; postural orthostatic tachycardia syndrome; mitral valve prolapse; pheochromocytoma and belongs to the drug class non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Labetalol 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 607

Labetalol hydrochloride 300 mg WATSON 607
Labetalol hydrochloride 300 mg WATSON 607
Labetalol hydrochloride 300 mg WATSON 607
Labetalol hydrochloride 300 mg WATSON 607
Labetalol hydrochloride
Imprint:
WATSON 607
Strength:
300 mg
Color:
Blue
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Non-cardioselective beta blockers
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0607
Inactive Ingredients:
lactose anhydrous
silicon dioxide colloidal
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
corn starch
water
titanium dioxide
FD&C Blue No. 2
aluminum oxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0457 Amerisource Health Services
00904-5930 Major Pharmaceuticals

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)